Biofrontera Inc.

BFRI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17,759-$20,131-$640-$37,713
Dep. & Amort.$1,149$1,064$1,172$540
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,019$1,045$1,852$129
Change in WC$6,212-$4,394$2,788-$1,505
Other Non-Cash-$891-$2,479-$21,371$11,834
Operating Cash Flow-$10,270-$24,895-$16,199-$26,715
Investing Activities
PP&E Inv.-$10-$5-$38-$11
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$5,118$0
Inv. Sales/Matur.$57$624$0$0
Other Inv. Act.-$50$0$0$0
Investing Cash Flow-$3$619-$5,156-$11
Financing Activities
Debt Repay.-$265$3,904$0$0
Stock Issued$0$4,507$9,391$29,938
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$15,100$0$4,630$13,253
Financing Cash Flow$14,835$8,411$14,021$43,191
Forex Effect$0$0$0$0
Net Chg. in Cash$4,562-$15,865-$7,334$16,465
Supplemental Information
Beg. Cash$1,543$17,408$24,742$8,277
End Cash$6,105$1,543$17,408$24,742
Free Cash Flow-$10,330-$24,900-$16,237-$26,726
Biofrontera Inc. (BFRI) Financial Statements & Key Stats | AlphaPilot